Michael Horberg to HIV Envelope Protein gp41
This is a "connection" page, showing publications Michael Horberg has written about HIV Envelope Protein gp41.
Connection Strength
0.343
-
Virologic outcomes of changing enfuvirtide to raltegravir in HIV-1 patients well controlled on an enfuvirtide based regimen: 24-week results of the CHEER study. J Acquir Immune Defic Syndr. 2009 Aug 01; 51(4):367-73.
Score: 0.343